menu search

Nikola cashes out european jv and refocuses on fuel cells at home

Cash-strapped Nikola Corp. is selling its stake in a European joint venture with Iveco Group for $35 million and 20.6 million shares of Nikola stock. ...

May 9, 2023, 9:23 am

Novavax reports positive results in trial of 3 vaccines for flu and covid, posts q1 loss and plan to cut 25% of workforce

Novavax Inc. NVAX reported positive results from three vaccine trials on Tuesday, one targeting both COVID and flu, one for stand-alone flu and one a ...

May 9, 2023, 6:43 am

Akero therapeutics: proof of concept with efx, sets up catalyst opportunities in 2023

Akero Therapeutics has a proof of concept in using EFX for the treatment of patients with NASH Fibrosis established in the ...

May 9, 2023, 4:37 am

Blueprint is well-positioned to capitalize on ism market (maintain 'buy')

Blueprint Medicines focuses on developing precision therapies for genomically defined cancers and blood disorders, with two approved drugs and multipl...

May 9, 2023, 2:28 am

Usdcad analysis – may 9, 2023

USDCAD has been experiencing a consolidation phase for the downtrend from 1.3667, after rebounding from...

May 9, 2023, 1:15 am

Usdjpy analysis – may 9, 2023

USDJPY has been in a consolidation phase for the downtrend from the high of 137.77. The pair has been i...

May 9, 2023, 1:07 am

Biorestorative therapies and northwell health enter into agreement to participate in the company’s phase 2 clinical trial

New York State’s largest health care provider will participate in BRTX’s clinical trial Expansive universe of patients and clinical sites from whi...

May 8, 2023, 11:00 am

Immunogen nearly triples on ovarian cancer drug phase 3 results

Commercial-state biotechnology company ImmunoGen Inc. NASDAQ: IMGN shares more than doubled on phase 3 ...

May 8, 2023, 8:31 am

Usdjpy analysis – may 7, 2023

The USDJPY currency pair has been moving sideways in a trading range between 127.21 and 137.90 for a while. As long as the resistance at 137.90 holds,...

May 7, 2023, 10:12 am

Akero therapeutics: excellent data, solid clinical potential, no major near term catalysts

AKRO will produce phase 2b SYMMETRY data in 4Q, but phase ...

May 7, 2023, 10:05 am

Former google executive details the next phase of ai and voices concerns

Former Google Chairman & CEO Eric Schmidt spoke with Yahoo Finance Live's Allie Garfinkle from the Milken Institute Global Conference 2023 about the d...

May 7, 2023, 12:00 am

Bdc weekly review: we are moving past the goldilocks phase

We take a look at the action in business development companies through the last week of April and highlight some of the key themes we are watching. BD...

May 6, 2023, 7:56 am

Galapagos stands strong on jyseleca positive clinical data

Galapagos' focuses on immunology and oncology, with its flagship Jyseleca being used to treat rheumatoid arthritis and ulcerative colitis in Europe an...

May 6, 2023, 1:59 am

Gold’s rising consolidation phase stalls, but quickly finds support following pullback

Gold seeing conflicting signals as week likely to end with a bearish candlestick pattern, while uptrend remains solid. The post Gold’s Rising Consol...

May 5, 2023, 10:19 pm

Gold's rising consolidation phase stalls, but quickly finds support following pullback

Gold seeing conflicting signals as week likely to end with a bearish candlestick pattern, while uptrend remains solid....

May 5, 2023, 6:19 pm

Eur/usd weekly forecast: inflation figures to confirm or deny fed’s and ecb’s stances

EUR/USD consolidative phase near year highs hints at higher highs ahead. The EUR/USD pair ends the week...

May 5, 2023, 3:59 pm

Chitogenx raises $3.9m to advance tissue repair research

ChitogenX Inc (CSE:CHGX, OTCQB:CHNXF) said it has closed its amended non-brokered private placement offering for gross proceeds of $3.86 million. The ...

May 5, 2023, 11:07 am

Bridgebio pharma reports first quarter 2023 financial results and business update

phase 3 ATTRibute-CM registrational trial of acoramidis for transthyretin amyloid cardiomyopathy (A...

May 4, 2023, 11:30 am

Kulr wins $1.1m contract with us army to develop high-energy battery packs

KULR Technology Group said it has been awarded a $1.13 million contract by the United States army to develop a high-energy battery storage platform us...

May 4, 2023, 9:19 am

Immunic reports positive results from part c of phase 1 clinical trial of imu-856 in patients with celiac disease

Immunic Inc (NASDAQ:IMUX) said the results from the part C portion of its phase 1 clinical trial of IMU...

May 4, 2023, 8:16 am


Search within

Pages Search Results: